Altered amino acid homeostasis in subjects affected by fibromyalgia

Clinical Biochemistry

Volumn 42, Issue 10-11, 2009, Pages 1064-1070

  Bazzichi, Laura ^a   Palego, Lionella ^a   Giannaccini, Gino ^a   Rossi, Alessandra ^a   De Feo, Francesca ^a   Giacomelli, Camillo ^a   Betti, Laura ^a   Giusti, Laura ^a   Mascia, Giovanni ^a   Bombardieri, Stefano ^a   Lucacchini, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Branched amino acids; Essential amino acids; Fatigue; Fibromyalgia; Muscle energy; Taurine; Tyrosine

Indexed keywords

ALANINE; ARGININE; ASPARAGINE; CATECHOLAMINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; ORNITHINE; PHENYLALANINE; PROLINE; SERINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FIBROMYALGIA; GASTROINTESTINAL ABSORPTION; HUMAN; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL;

AMINO ACIDS; AMINO ACIDS, BRANCHED-CHAIN; AMINO ACIDS, ESSENTIAL; AMINO ACIDS, SULFUR; BIOLOGICAL TRANSPORT; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; FIBROMYALGIA; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; SLEEP;

EID: 67349225276     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.02.025     Document Type: Article

References (55)

1. Wolfe F., Smythe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 33 (1990) 160-172
2. Neeck G., and Crofford L.J. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum. Dis. Clin. North Am. 26 (2000) 989-1002
3. Bazzichi L., Giannaccini G., Betti L., et al. Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res. Ther. 8 (2006) R99
4. Bazzichi L., Rossi A., Giuliano T., et al. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin. Rheumatol. 26 (2007) 2115-2120
5. Russell I.J., Orr M.D., Littman B., et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 37 (1994) 1593-1601
6. Giovengo S.L., Russell I.J., and Larson A.A. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J. Rheumatol. 26 (1999) 1564-1569
7. Staud R., and Spaeth M. Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia. CNS Spectr. 13 (2008) 12-17
8. Larson A.A., Giovengo S.L., Russell I.J., and Michalek J.E. Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 87 (2000) 201-211
9. Raymond J.R., Mukhin Y.V., Gelasco A., et al. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol. Ther. 92 (2001) 179-212
10. Moldofsky H., and Warsh J.J. Plasma tryptophan and musculoskeletal pain in non-articular rheumatism ("fibrositis syndrome"). Pain 5 (1978) 65-71
11. Russell I.J., Michalek J.E., Vipraio G.A., Fletcher E.M., and Wall K. Serum amino acids in fibrositis/fibromyalgia syndrome. J. Rheumatol. Suppl. 19 (1989) 158-163
12. Yunus M.B., Dailey J.W., Aldag J.C., Masi A.T., and Jobe P.C. Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J. Rheumatol. 19 (1992) 90-94
13. Neeck G., and Riedel W. Neuromediator and hormonal perturbations in fibromyalgia syndrome: results of chronic stress?. Baillieres Clin. Rheumatol. 8 (1994) 763-775
14. Maes M., Verkerk R., Delmeire L., Van Gastel A., van Hunsel F., and Scharpé S. Serotonergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgia. Psychiatry Res. 97 (2000) 11-20
15. Rossini M., Di Munno O., Valentini G., et al. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients. Clin. Exp. Rheumatol. 25 (2007) 182-188
16. Kirvelä O., Jaatinen J., Scheinin H., and Kanto J. The effects of branched chain amino acid infusion on pain perception and plasma concentrations of monoamines. Pharmacol. Biochem. Behav. 60 (1998) 77-82
17. Sarchielli P., Di Filippo M., Nardi K., and Calabresi P. Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr. Pain Headache Rep. 11 (2007) 343-351
18. Lucca A., Lucini V., Catalano M., and Smeraldi E. Neutral amino acid availability in two major psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 19 (1995) 615-626
19. Altamura C., Maes M., Dai J., and Meltzer H.Y. Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. Eur. Neuropsychopharmacol. 5 (1995) 71-75
20. Fischer A.A. Pressure tolerance over muscles and bones in normal subjects. Arch. Phys. Med. Rehabil. 67 (1986) 406-409
21. Dictionary of the rheumatic diseases: signs and symptoms (1988) Vol. 1 prepared by ARA Glossary Committee American Rheumatism Associations, third edition).
22. Gibson C.J. Control of monoamine synthesis by precursor availability. In: Lajtha A. (Ed). Handbook of neurochemistry (1985), Plenum Press, New York 309-324
23. Jepson J.B. Hartnup disease. In: Stanbury J.B., Wyngaarden J.B., and Fredrickson D.S. (Eds). The metabolic basis of inherited disease (1972), McGraw-Hill, New York 1486
24. Scriver C.R. Familial iminoglycinuria. In: Stanbury J.B., Wyngaarden J.B., and Fredrickson D.S. (Eds). The metabolic basis of inherited disease (1972), McGraw-Hill, New York 1520
25. Schneider J.A., and Seegmille J.E. Cystinosis and the Fanconi syndrome. In: Stanbury J.B., Wyngaarden J.B., and Fredrickson D.S. (Eds). The metabolic basis of inherited disease (1972), McGraw-Hill, New York 1581
26. Blomstrand E., Hassmén P., Ekblom B., and Newsholme E.A. Administration of branched-chain amino acids during sustained exercise-effects on performance and on plasma concentration of some amino acids. Eur. J. Appl. Physiol. Occup. Physiol. 63 (1991) 83-88
27. Freund H.R., James J.H., and Fischer J.E. Nitrogen-sparing mechanisms of singly administered branched-chain amino acids in the injured rat. Surgery 90 (1981) 237-243
28. Newsholme E.A., Blomstrand E., and Ekblom B. Physical and mental fatigue: metabolic mechanisms and importance of plasma amino acids. Br. Med. Bull. 48 (1992) 477-495
29. Bazzichi L., Giannaccini G., Betti L., et al. ATP, calcium and magnesium levels in platelets of patients with primari fibromyalgia. Clin. Biochem. 41 (2008) 1084-1090
30. Wood P.B., Schweinhardt P., Jaeger E., et al. Fibromyalgia patients show an abnormal dopamine response to pain. Eur. J. Neurosci. 25 (2007) 3576-3582
31. Holman A.J. Fibromyalgia and pramipexole: promise and precaution. J. Rheumatol. 30 (2003) 2733
32. Holman A.J., and Myers R.R. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. 52 (2005) 2495-2505
33. Buskila D., Cohen H., Neumann L., and Ebstein R.P. An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 9 (2004) 730-731
34. Malt E.A., Olafsson S., Aakvaag A., Lund A., and Ursin H. Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. J. Affect. Disord. 75 (2003) 77-82
35. Trivedi M.H., Desaiah D., Ossanna M.J., Pritchett Y.L., Brannan S.K., and Detke M.J. Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine. Int. Clin. Psychopharmacol. 23 (2008) 161-169
36. Sproule B.A., Hazra M., and Pollock B.G. Desvenlafaxine succinate for major depressive disorder. Drugs Today 44 (2008) 475-487
37. Crofford L.J. Pain management in fibromyalgia. Curr. Opin. Rheumatol. 20 (2008) 246-250
38. Reinstein D.K., Lehnert H., and Wurtman R.J. Dietary tyrosine suppresses the rise in plasma corticosterone following acute stress in rats. Life Sci. 37 (1985) 2157-2163
39. Hao S., Avraham Y., Bonne O., and Berry E.M. Separation-induced body weight loss, impairment in alternation behavior, and autonomic tone: effects of tyrosine. Pharmacol. Biochem. Behav. 68 (2001) 273-281
40. Magill R.A., Waters W.F., Bray G.A., et al. Effects of tyrosine, phentermine, caffeine d-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Nutr. Neurosci. 6 (2003) 237-246
41. Neri D.F., Wiegmann D., Stanny R.R., Shappell S.A., McCardie A., and McKay D.L. The effects of tyrosine on cognitive performance during extended wakefulness. Aviat. Space Environ. Med. 66 (1995) 313-319
42. Woodside K.H., and Mortimore G.E. Suppression of protein turnover by amino acids in the perfused rat liver. J. Biol. Chem. 247 (1972) 6474-6481
43. Hauser S.L., Doolittle T.H., Lopez-Bresnahan M., et al. An antispasticity effect of threonine in multiple sclerosis. Arch. Neurol. 49 (1992) 923-926
44. Richmond V.L. Incorporation of methylsulfonylmethane sulfur into guinea pig serum proteins. Life Sci. 39 (1986) 263-268
45. Tabakoff B., Eriksson C.J., and von Wartburg J.P. Methionine lowers circulating levels of acetaldehyde after ethanol ingestion. Alcohol. Clin. Exp. Res. 13 (1989) 164-171
46. Smythies J.R., and Halsey J.H. Treatment of Parkinson's disease with l-methionine. South Med. J. 77 (1984) 1577
47. Uden S., Bilton D., Nathan L., Hunt L.P., Main C., and Braganza J.M. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Aliment. Pharmacol. Ther. 4 (1990) 357-371
48. Bell K.M., Plon L., Bunney Jr. W.E., and Potkin S.G. S-adenosylmethionine treatment of depression: a controlled clinical trial. Am. J. Psychiatry 145 (1988) 1110-1114
49. Tavoni A., Vitali C., Bombardieri S., and Pasero G. Evaluation of S-adenosylmethionine in primary fibromyalgia. A double-blind crossover study. Am. J. Med. 83 (1987) 107-110
50. Vahora S.A., and Malek-Ahmadi P. S-adenosylmethionine in the treatment of depression. Neurosci. Biobehav. Rev. 12 (1988) 139-141
51. Redmond H.P., Stapleton P.P., Neary P., and Bouchier-Hayes D. Immunonutrition: the role of taurine. Nutrition 14 (1998) 599-604
52. Lombardini J.B. Taurine: retinal function. Brain Res. Brain Res. Rev. 16 (1991) 151-169
53. Kendler B.S. Taurine: an overview of its role in preventive medicine. Prev. Med. 18 (1989) 79-100
54. Birdsall T.C. Therapeutic applications of taurine. Altern. Med. Rev. 3 (1998) 128-136
55. Chesney R.W. Taurine: its biological role and clinical implications. Adv. Pediatr. 32 (1985) 1-42